FDA highlights ideas to improve time to market

06/4/2007 | Deseret News (Salt Lake City), The

The FDA's Critical Path Initiative aims to speed drugs and medical devices from concept to cure and sees personalized medicine as one way to cut R&D costs and time. "We are on the verge of the most profound transformation in the history of medicine," FDA commissioner Dr. Andrew von Eschenbach said.

View Full Article in:

Deseret News (Salt Lake City), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN